July 26th 2025
A recent study reveals that many Americans neglect eye care due to cost and urgency misconceptions, despite the significant impact on daily life.
Dr. Lee becomes new University of Michigan chairman
April 1st 2012Paul P. Lee, MD, JD, has come full circle. After earning his undergraduate and medical degrees from the University of Michigan in the 1980s, Dr. Lee has returned as chairman of the Department of Ophthalmology and Visual Sciences and holder of the F. Bruce Fralick scholarship.
Read More
Optimize outcome by IOL calculations
April 1st 2012Optimizing outcomes with correct IOL calculations for combined Descemet's stripping automated endothelial keratoplasty, cataract extraction, and IOL implantation procedures can be achieved with the same techniques that are used in cataract surgery.
Read More
Thermal pulsation device clears gland blockages
April 1st 2012The FDA clearance this past February for a second-generation version of a proprietary device allows physicians to treat both eyes simultaneously for meibomian gland dysfunction and evaporative dry eye in a relatively painless in-office procedure.
Read More
Study compares drainage devices
April 1st 2012Interim results after 2 years of follow-up in the Ahmed Versus Baerveldt Study provide prospective evidence that aqueous drainage devices may be effective treatments for refractory glaucoma, and demonstrate the advantages and disadvantages of each.
Read More
Transcleral or endoscopic cyclophotocoagulation support glaucoma therapy
April 1st 2012Results from a retrospective review of outcomes after transcleral or endoscopic cyclophotocoagulation for a variety of glaucoma conditions provide additional information on the efficacy and safety of these procedures, including in select subgroups composed of eyes with either neovascular glaucoma or better than count fingers vision.
Read More
Lens now has better safety profile
April 1st 2012Data from patients with the V4 model of the posterior chamber, foldable collagen copolymer phakic IOL implanted show that it provides excellent refractive and visual results, and, thanks to design modifications, a safety profile that is favorable, at least over the short term.
Read More
Male gender and younger age were identified as risk factors for IOP elevation after dexamethasone implant treatment in retinal vein occlusion in a recent subset analysis, but the elevated IOP did not seem to affect improvement in visual acuity or anatomic outcomes evaluated with optical coherence tomography.
Read More
Injections improve acuity in retinal vein occlusion
March 1st 2012The HORIZON Retinal Vein Occlusion Study, an extension study of the BRAVO Study, found that long-term multiple intravitreal injections of ranibizumab were well-tolerated by patients with branch retinal vein occlusion and central retinal vein occlusion.
Read More